Marketwatch US concerns on key drugs wreck Aurobindo’s plan to buy Sandoz biz Admin April 3, 2020 The FTC was not convinced on several issues pertaining to continued availability of these critical drugs and didn’t accept the alternatives suggested by the two companies to allay the concerns of the regulator, said people in the know. – Stocks-Markets-Economic Times Share on Facebook Tweet it Pin it Share it Email
